Skip to main content

Deborah H. Telman

Equibles does not estimate personal net worth.

Get an email with a short summary when AtriCure, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATRC alerts

About Deborah H. Telman

Deborah H. Telman is recorded as Board Member at AtriCure, Inc. (ATRC). The newest filing on record that lists Deborah H. Telman as Board Member at AtriCure, Inc. (ATRC) is dated April 6, 2026. Earlier roles on record: General Counsel at Organon & Co. (OGN) until July 22, 2022. AtriCure, Inc. reported in an 8-K filed May 20, 2025 that Deborah H. Telman was appointed Director, effective May 19, 2025. AtriCure, Inc. reported in an 8-K filed May 14, 2024 that Deborah H. Telman was appointed Director, effective May 13, 2024. Organon & Co. reported in an 8-K filed July 12, 2022 that Deborah H. Telman resigned as Executive Vice President, General Counsel and Corporate Secretary, effective July 22, 2022. The proxy statement of Organon & Co. reports total compensation of $4,112,953 for Deborah H. Telman in fiscal 2021, including a base salary of $670,357. AtriCure, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at AtriCure, Inc. includes Michael Carrel (CEO and Board Member), Michael H. Carrel (CEO and Board Member), Robert S. White (Chairman) and 7 others.

“Each nominee for director was duty elected to serve one-year terms expiring at the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
AtriCure, Inc. Form 8-K, filed May 20, 2025 · Read the filing
“Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.”
AtriCure, Inc. Form 8-K, filed May 14, 2024 · Read the filing

Affiliation history

Company network

Current role

Medical Instruments & Supplies · Healthcare

Board Member

Drug Manufacturers - General · Healthcare

General Counsel

2021-06-02–2022-07-22

Leadership on record at AtriCure, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Organon & Co. (OGN) $670,357 $4,112,953

Recent activity